PortViewPortView
Profusa logo

Profusa (PFSA) Stock Analysis

NASDAQHealthcareMedical - Devices

$2.74-4.86%
1-year price historyRange $2.72 – $3,459.00
52-week range$2.74
$2.66$4,500.00

What Profusa does

Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Key metrics

Market cap
$3.02M
P/E (TTM)
-0.03
EPS (TTM)
$-99.88
Beta
0.44
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$7.36
200-day avg
$304.83
52-week high
$4,500.00
52-week low
$2.66
CEO
Jack E. Stover

ETFs linked to PFSA

Broad-market and Healthcare sector ETFs an investor holding Profusa is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PFSA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze PFSA in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Profusa?
Profusa trades under the ticker PFSA on NASDAQ.
Which exchange is PFSA listed on?
PFSA is listed on NASDAQ.
What sector does Profusa operate in?
Profusa is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze PFSA in a portfolio?
PortView shows PFSA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.